Curative Biotechnology (Curative Biotechnology) Net Issuance of Preferred Stock : $0.16 Mil (TTM As of Mar. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Curative Biotechnology Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Curative Biotechnology's net issuance of preferred for the three months ended in Mar. 2023 was $0.16 Mil. The number is positive, which means that Curative Biotechnology has received more cash from issuing preferred shares than it has paid to buy back preferred shares quarterly.

Curative Biotechnology's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2023 was $0.16 Mil.

Curative Biotechnology Net Issuance of Preferred Stock Historical Data

The historical data trend for Curative Biotechnology's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biotechnology Net Issuance of Preferred Stock Chart

Curative Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

0.12

Curative Biotechnology Quarterly Data
	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	0.16

Curative Biotechnology Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.16 Mil.

Curative Biotechnology Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Curative Biotechnology's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biotechnology (Curative Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curative Biotechnology Inc (OTCPK:CUBT) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

1825 NW Corporate Boulevard, Suite 110, Boca Raton, FL, USA, 33431

Website

https://www.curativebiotech.com

Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.